WEBINAR: The Commercial Considerations of Microbiome-Based Therapeutics

Terms and Conditions  |  Privacy Policy

† You may still receive emails from us regarding any current registrations or orders.

WATCH THE WEBINAR

WATCH THE WEBINAR

The advent of microbiome-based therapeutics will offer physicians and their patients novel treatment options. They will be very different in their composition when compared to current therapies that are all based on small and large molecules.

This webinar explores what might be the regulatory considerations, customer expectations, messaging implications, and other factors involved in launching these therapeutics.

What are the key issues that commercial teams (marketing, market research, sales, managed care, etc.) will need to address to ensure that the therapeutic promise of these agents translates into commercial success?

Presented by JP Benya, Vice President, Commercial at Assembly Biosciences

ABOUT THE WEBINAR

Fix the following errors:
Hide